Dr. Michelle Ploughman was supported by a Canadian Institutes for Health Research (Institute of Aging) Postdoctoral Fellowship. Her research was supported by the Newfoundland and Labrador Centre for Applied Health Research, Health Care Foundation, and Physiotherapy Foundation of Canada. She is also an academic editor of PeerJ.
Chelsea Harris, Elizabeth Wallack, Olivia Drodge, Serge Beaulieu, Stephen Hogan, Dr. Penelope Alderdice, Dr. A. Dessa Sadovnick, Dr. Luanne M. Metz, and Dr. Nancy Mayo have no disclosures or conflicts of interest to report.
Dr. John Fisk is the Director of the endMS Atlantic Regional Research and Training Centre, which is funded by the Multiple Sclerosis Society of Canada. He receives research funding from the Canadian Institutes of Health Research (CIHR) and in the past has received grants, honoraria and consultation fees from Astra- Zeneca, Bayer, Biogen-Idec Canada, Heron Evidence Development Limited, Hoffmann-La Roche, MAPI Research Trust, Novartis, Sanofi-Aventis, Serono Canada, and QualityMetric Inc.
Dr. Paul O'Connor has received consulting fees and/or research support for MS trials from Actelion, Bayer, Biogen Idec, BioMS, Cognosci, Daiichi Sankyo, EMD Serono, Genentech, Genmab, Novartis, Roche, Sanofi Aventis, Teva and Warburg Pincus.
Dr. Sarah Morrow has received research support from Biogen Idec and Novartis Canada, and received support for speaking engagement and advisory panels for Bayer, Biogen Idec, EMDSerono and Teva Neurosciences and Novartis Canada.
Dr. Penelope Smyth has served on scientific advisory boards for Novartis an EMD Serono. She has received funding for travel to pharmaceutically sponsored events by EMD Serono. She has received honoraria for speaking, facilitating and chairing from Novartis and EMD Serono as well as from the MS Society of Canada. She has received academic research support for medical education research from the Arnold P. Gold Foundation, and the Teaching and Learning Enhancement Fund from the University of Alberta.
Dr. Ruth Ann Marrie receives research funding from: Canadian Institutes of Health Research, Multiple Sclerosis Society of Canada, Multiple Sclerosis Scientific Research Foundation, Rx & D Health Research Foundation, and has conducted clinical trials funded by Sanofi-Aventis.
Dr. Katherine Knox received grant funding from Saskatoon City Hospital Foundation and MS Society of Canada, educational CME event grant funding from Bayer HealthCare Pharmaceuticals, honoraria /travel grant from Biogen and Teva. She was a member of the CIHR and MS Society of Canada Scientific Expert Working Group on CCSVI and MS.
Dr. Mark Stefanelli has served on advisory boards for Biogen Idec and Novartis and has been provided speaker/travel support by Teva Neuroscience. His research was supported by Genzyme and Biogen.
Dr. Marshall Godwin’s research is funded by the Canadian Institutes of Health Research, Public Health Agency of Canada, Health Canada, and Newfoundland and Labrador Centre for Applied Health Research. He reports no conflicts of interest.